menu
    • menu

    Company profile for MiMedx

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MiMedx is an industry leader in advanced wound care and a therapeutic biologics company. As a company, we are driven to bring hope to people with hard-to-heal wounds. Our ability to advance science will further differentiate the value of our business and set the foundation for our platform portfolio to address other areas of unmet need.MiMedx has supplied over 2 million allografts, through both direct and consignment shipments...
    MiMedx is an industry leader in advanced wound care and a therapeutic biologics company. As a company, we are driven to bring hope to people with hard-to-heal wounds. Our ability to advance science will further differentiate the value of our business and set the foundation for our platform portfolio to address other areas of unmet need.MiMedx has supplied over 2 million allografts, through both direct and consignment shipments.Patients suffering from chronic, hard-to-heal wounds are one of the most underdiagnosed, undertreated, underserved populations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MiMedxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1775 West Oak Commons Ct. NE Marietta, GA 30062
    Telephone
    Telephone
    888.543.1917
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mimedx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mimedx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MIMEDX Provides Update On Epieffect Randomized Controlled Trial
    MIMEDX Provides Update On Epieffect Randomized Controlled Trial

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187243/0/en/MIMEDX-Provides-Update-on-EPIEFFECT-Randomized-Controlled-Trial.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    MIMEDX To Participate In Upcoming Investor Conferences
    MIMEDX To Participate In Upcoming Investor Conferences

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185066/0/en/MIMEDX-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Mimedx Comments On CY 2026 Medicare Physician Fee Schedule Rule
    Mimedx Comments On CY 2026 Medicare Physician Fee Schedule Rule

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179427/0/en/MIMEDX-Comments-on-CY-2026-Medicare-Physician-Fee-Schedule-Final-Rule.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Mimedx Announces Record Revenue For Third Quarter 2025
    Mimedx Announces Record Revenue For Third Quarter 2025

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176825/0/en/MIMEDX-Announces-Record-Revenue-for-Third-Quarter-2025.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    MIMEDX To Host Q3 2025 Financial Results Call On October 29
    MIMEDX To Host Q3 2025 Financial Results Call On October 29

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166997/0/en/MIMEDX-to-Host-Third-Quarter-2025-Operating-and-Financial-Results-Conference-Call-on-October-29.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    MIMEDX Announces Launch Of EPIXPRESS
    MIMEDX Announces Launch Of EPIXPRESS

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161809/0/en/MIMEDX-Announces-Launch-of-EPIXPRESS.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search